Evidence map›Paper›PMID 38617322›Full record

ArticlebioRxiv : the preprint server for biology2024

Embryonic motor neuron programming factors reactivate immature gene expression and suppress ALS pathologies in postnatal motor neurons.

Emily R Lowry, Tulsi Patel, Jonathon A Costa, Elizabeth Chang, Shahroz Tariq, Hranush Melikyan, Ian M Davis, Siaresh Aziz, Georgia Dermentzaki, Francesco Lotti and 1 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Emily R LowryDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center; New York, NY, 10032, USA.ORCID 0000-0002-8412-3168
Tulsi PatelDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center; New York, NY, 10032, USA.
Jonathon A CostaDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center; New York, NY, 10032, USA.
Elizabeth ChangDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center; New York, NY, 10032, USA.
Shahroz TariqDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center; New York, NY, 10032, USA.
Hranush MelikyanDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center; New York, NY, 10032, USA.
Ian M DavisDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center; New York, NY, 10032, USA.
Siaresh AzizDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center; New York, NY, 10032, USA.
Georgia DermentzakiDepartment of Neurology, Columbia University Irving Medical Center; New York, NY, 10032, USA.
Francesco LottiDepartment of Neurology, Columbia University Irving Medical Center; New York, NY, 10032, USA.
Hynek WichterleDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center; New York, NY, 10032, USA.
Columbia University Irving Medical Center · US

Funding

Distal enhancers controlling motor neuron gene expression programR01NS109217 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WICHTERLE, HYNEK · 2019 to 2022
$2.1M
Transcriptional Control of Motor Neuron MaturationR01NS116141 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WICHTERLE, HYNEK · 2020 to 2024
$1.9M
METTL3-mediated regulation of motor neuron functionR01AG084965 · NIA · HUNTER COLLEGE · PI Francesco Lotti · 2023 to 2026
$1.1M
Defining Motor Neuron Diversity from Embryo to Adulthood and Generating Tools for in Vivo and in Vitro AccessR00NS121136 · NINDS · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Tulsi Patel · 2024 to 2026
$672k
SMN post-translational modification in Spinal Muscular AtrophyR21NS101575 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LOTTI, FRANCESCO · 2017 to 2018
$440k
Defining motor neuron diversity from embryo to adulthood and generating tools for in vivo and in vitro accessK99NS121136 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PATEL, TULSI · 2021 to 2022
$272k
NIA NIH HHS R01 AG084965NINDS NIH HHS K99 NS121136NINDS NIH HHS R00 NS121136NINDS NIH HHS R01 NS109217NINDS NIH HHS R01 NS116141NINDS NIH HHS R21 NS101575
6 · The paper itself

Abstract

Aging is a major risk factor in amyotrophic lateral sclerosis (ALS) and other adult-onset neurodegenerative disorders. Whereas young neurons are capable of buffering disease-causing stresses, mature neurons lose this ability and degenerate over time. We hypothesized that the resilience of young motor neurons could be restored by re-expression of the embryonic motor neuron selector transcription factors ISL1 and LHX3. We found that viral re-expression of ISL1 and LHX3 reactivates aspects of the youthful gene expression program in mature motor neurons and alleviates key disease-relevant phenotypes in the SOD1

Identifiers

PMID38617322
PMCPMC11014605
OpenAlexW4393994552

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.